Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for Thromboprophylaxis in Critically Ill Patients
NCT02095509Phase 4Completed
- Sponsor
- Tampere University Hospital
- Start
- Mar 2014
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Tampere University Hospital. Started Mar 2014; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02095509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095509.